C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/17/2002	WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/17/2002	WO2002080659A1 Nucleic acids that control reproductive development in plants
10/17/2002	WO2002063021A3 Nucleotide sequence mediating male fertility and method of using same
10/17/2002	WO2002060933A3 Thioredoxin derived from h. pylori, which is capable of inhibiting nf-kappa b activation
10/17/2002	WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002	WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002	WO2002044205A3 Peptides from ag85 of mycobacterium and uses thereof
10/17/2002	WO2002043757A3 Medicament for preventing or treating tumors caused by human papilloma virus type 18
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036804A3 Method for detecting hematopoietic stem cells
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002036146A3 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy
10/17/2002	WO2002031111A3 Novel nucleic acids and polypeptides
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002026824A3 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues
10/17/2002	WO2002022837A3 Identification and characterization of a dwarf and late flowering 2 phenotype (dlf2) in arabidopsis
10/17/2002	WO2002020548A9 Monocot seeds with increased lignan content
10/17/2002	WO2002018568A3 Molecules involved in the regulation of insulin in resistance syndrome (irs)
10/17/2002	WO2002016435A3 Human 7tm proteins and polynucleotides encoding the same
10/17/2002	WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002	WO2002010192A9 Somatostatin analogues
10/17/2002	WO2002009645A3 Intercellular transport protein linked to an antigen as a molecular vaccine
10/17/2002	WO2002008260A3 Bstp-ecg1 protein and related reagents and methods of use thereof
10/17/2002	WO2002008247A3 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2002002133A3 Peptide composition for treatment of periodontal diseases and prevention of skin aging
10/17/2002	WO2002000843A3 56739, a novel cub domain containing protein and uses thereof
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001096585A3 Modulation of abscisic acid signal transduction in plants
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001084148A3 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
10/17/2002	WO2001079294A3 Human proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2001077378A3 Diagnosis of diseases associated with dna adducts
10/17/2002	WO2001074851A3 Novel proteins and nucleic acids encoding same
10/17/2002	WO2001060847A9 Avirulent, immunogenic flavivirus chimeras
10/17/2002	WO2001060839A9 Method for refolding recombinant endostatin
10/17/2002	WO2001059118A9 43239, a gpcr-like molecule and uses thereof
10/17/2002	WO2001059117A9 Seven-transmembrane proteins/g-protein coupled receptors
10/17/2002	WO2001059116A9 19459 protein, a human g-protein coupled seven transmembrane receptor
10/17/2002	WO2001059094A9 Method of regulating transcription in a cell by altering remodeling of cromatin
10/17/2002	WO2001058922A9 Method and compositions for treating hepatocellular cancer
10/17/2002	WO2001057275A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
10/17/2002	WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	WO1998002456A3 Human c-type lectin
10/17/2002	US20020152502 Transgenic plant; tolerance of environment stresses
10/17/2002	US20020152501 Nucleic acids that control seed and fruit development in plants
10/17/2002	US20020152500 Tissue-preferred promoter from maize
10/17/2002	US20020152499 Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants
10/17/2002	US20020152498 Mutant plant
10/17/2002	US20020152497 Nucleic acid fragments encoding proteins involved in stress response
10/17/2002	US20020152496 Coleopteran toxin proteins of bacillus thuringiensis
10/17/2002	US20020152492 Modulate gene expression
10/17/2002	US20020152489 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
10/17/2002	US20020152486 Transgenic animal; gene therapy; genetic disorders; cardiovascular disorders
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020152483 Genetic engineering; prevention fat accumulation
10/17/2002	US20020152480 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation
10/17/2002	US20020152479 Car modulators: screening and treatment of hypercholesterolemia
10/17/2002	US20020151710 Fusion protein delivery system and uses thereof
10/17/2002	US20020151709 Obtained from mutagenic strains of Bacillus thuringiensis encoding endotoxins
10/17/2002	US20020151708 DNA encoding proteins that inhibit Hsp70 function
10/17/2002	US20020151707 Soluble, fused major histocompatability complexes and peptide complexes; glutamate decarboxylase; autoimmunity
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151705 DNA encoding orphan SNORF49 receptor
10/17/2002	US20020151704 Recombinant nucleic acid sequences; hybridization; open reading frames; G-protein coupled receptors
10/17/2002	US20020151701 Tumor suppressor proteins; mutations; diagnosis; genetic disorders
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151697 DNA encoding orphan SNORF68 receptor
10/17/2002	US20020151696 Detecting/diagnosing and treating metallopeptidase-related disorders; detecting/diagnosing human ribosyltransferase-related disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151692 Novel polypeptides and nucleic acids encoding same
10/17/2002	US20020151691 Class II transactivators (CIITA); major histocompatability complex; gene expression inhibition; cloning; vaccines; transcriptional promoter activity
10/17/2002	US20020151687 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/17/2002	US20020151686 Polypeptide for use in the treatment and prevention of infections
10/17/2002	US20020151685 Polypeptide for use in the treatment and prevention of autoimmune and allergic disease
10/17/2002	US20020151681 Nucleotide sequences coding protein for use gene therapy in the detection and treatment of cancer, urogenital and sexual disorders
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151678 Prophylaxis and therapy of acquired immunodeficiency syndrome
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151646 Comprises glutamic acid, sodium glutamate, or glycine; for measurement of coagulation factor; sensitivity; blood screening; freeze-drying
10/17/2002	US20020151580 Synthetic spiroketal pyranes as potent anti-cancer agents and use
10/17/2002	US20020151516 Carrier:nucleic acids complexes containing nucleic acids encoding anti-angiogenic peptides and their use in gene therapy
10/17/2002	US20020151515 Preparation and use of superior vaccines
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151510 Methods and compositions for the treatment of human immunodeficiency virus infection
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151496 Treatment of spinal cord damage, spinal cord trauma, neuronal tissue damage produced by ischemic attack
10/17/2002	US20020151495 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of glucose-dependent insulinotropic polypeptide
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002	US20020151492 Tissue-specific markers for enhancing diagnosis, staging, and treatment of cancer, as well as to detect metastases of tumors derived from that tissue
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151486 Stimulating and modulating bone cell differentiation and bone formation; bone disorders including osteopetrosis and osteoporosis; genetic engineeing; gene therapy;
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof

1 ... 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 ... 2916